Molecular Diagnostics Market Update 2024: to Reach USD 23.9 billion by 2030, Claims AMR Report
Molecular Diagnostics Market Size, Share 2024
North America holds the dominating share in the molecular diagnostics market. The region has a relatively high prevalence of chronic diseases such as cancer
PORTLAND, OREGON, UNITED STATES, April 30, 2024 /EINPresswire.com/ -- ๐๐ง๐๐ซ๐๐๐ฌ๐ ๐ข๐ง ๐ญ๐ก๐ ๐ฉ๐ซ๐๐ฏ๐๐ฅ๐๐ง๐๐ ๐จ๐ ๐ข๐ง๐๐๐๐ญ๐ข๐จ๐ฎ๐ฌ ๐๐ข๐ฌ๐๐๐ฌ๐๐ฌ ๐๐ง๐ ๐ฏ๐๐ซ๐ข๐จ๐ฎ๐ฌ ๐ญ๐ฒ๐ฉ๐๐ฌ ๐จ๐ ๐๐๐ง๐๐๐ซ ๐๐ซ๐ข๐ฏ๐๐ฌ ๐ญ๐ก๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐ ๐ญ๐ก๐ ๐ฆ๐จ๐ฅ๐๐๐ฎ๐ฅ๐๐ซ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ. ๐๐ง ๐ญ๐ก๐ ๐จ๐ญ๐ก๐๐ซ ๐ก๐๐ง๐, ๐ฌ๐ญ๐ซ๐ข๐ง๐ ๐๐ง๐ญ ๐ซ๐๐ ๐ฎ๐ฅ๐๐ญ๐จ๐ซ๐ฒ ๐ซ๐๐ช๐ฎ๐ข๐ซ๐๐ฆ๐๐ง๐ญ๐ฌ ๐๐จ๐ซ ๐ญ๐ก๐ ๐๐ฉ๐ฉ๐ซ๐จ๐ฏ๐๐ฅ ๐จ๐ ๐ง๐๐ฐ ๐ฆ๐จ๐ฅ๐๐๐ฎ๐ฅ๐๐ซ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐ญ๐๐๐ก๐ง๐ข๐ช๐ฎ๐๐ฌ ๐๐ซ๐ ๐๐ฑ๐ฉ๐๐๐ญ๐๐ ๐ญ๐จ ๐ก๐ข๐ง๐๐๐ซ ๐ญ๐ก๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐ ๐ญ๐ก๐ ๐ฆ๐๐ซ๐ค๐๐ญ. ๐๐จ๐ฐ๐๐ฏ๐๐ซ, ๐ฌ๐ฎ๐ซ๐ ๐ ๐ข๐ง ๐๐๐จ๐ฉ๐ญ๐ข๐จ๐ง ๐จ๐ ๐ญ๐ก๐ ๐ฆ๐จ๐ฅ๐๐๐ฎ๐ฅ๐๐ซ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐ฆ๐๐ซ๐ ๐ข๐ง๐ ๐๐๐จ๐ง๐จ๐ฆ๐ข๐๐ฌ ๐ข๐ฌ ๐ฉ๐ซ๐จ๐ฃ๐๐๐ญ๐๐ ๐ญ๐จ ๐จ๐๐๐๐ซ ๐ง๐ฎ๐ฆ๐๐ซ๐จ๐ฎ๐ฌ ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ.
Allied Market Research published a report, titled, "Molecular Diagnostics Market by Type (Instruments, Reagents, Software & Services), by Technology (Polymerase Chain Reaction (PCR), Hybridization, DNA sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Others), by Application (Infectious diseases, Oncology, Genetic testing, Blood screening, Others), by End User (Hospital, Reference Labortories, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030. " According to the report, the global molecular diagnostics industry was estimated at $9.2 billion in 2020, and is anticipated to hit $23.9 billion by 2030, registering a CAGR of 9.86% from 2021 to 2030.
The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/2170
๐๐จ๐ฉ ๐๐จ๐ฅ๐๐๐ฎ๐ฅ๐๐ซ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
โข Abbott Laboratories
โข Becton
โข Hoffmann-La Roche AG
โข Qiagen N.V.
โข Hologic Corporation
โข Grifols
โข Danaher Corporation, S.A.
โข Agilent Inc.
โข Dickinson and Company
โข BioMรฉrieux SA
โข Siemens Healthcare GmbH
๐๐จ๐ฅ๐๐๐ฎ๐ฅ๐๐ซ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง
Based on product type, the reagents segment accounted for more than half of the global molecular diagnostics market share in 2020, and is anticipated to rule the roost by 2030. The same segment would also cite the fastest CAGR of 10.16% throughout the forecast period. Advancement in R&D activities in pharmaceutical & biotechnology industry, increase in demand for reagents, and surge in adoption of point-of-care testing drive the segment growth.
Based on application, the infectious diseases segment held nearly half of the global molecular diagnostics market revenue in 2020, and is expected to lead the trail by 2030, due to the growing incidence of infectious diseases such as SARS-COV-19. The genetic testing segment, on the other hand, would manifest the fastest CAGR of 10.31% from 2021 to 2030. This is attributed to the increase in the prevalence of genetic diseases among individuals across the world.
Based on region, North America, held the major share in 2020, generating more than two-fifths of the global molecular diagnostics market, due to the presence of large number of key players across the region. At the same time, the market across Asia-Pacific would grow at the fastest CAGR of 10.78% by 2030, owing to higher adoption & increased use of molecular diagnostics, rapidly growing geriatric population, and rise in the incidence of infectious diseases across the province.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/2170
Key Benefits For Stakeholders
โข This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the molecular diagnostics market analysis from 2020 to 2030 to identify the prevailing molecular diagnostics market opportunities.
โข The market research is offered along with information related to key drivers, restraints, and opportunities.
โข Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
โข In-depth analysis of the molecular diagnostics market segmentation assists to determine the prevailing market opportunities.
โข Major countries in each region are mapped according to their revenue contribution to the global market.
โข Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
โข The report includes the analysis of the regional as well as global molecular diagnostics market trends, key players, market segments, application areas, and market growth strategies.
๐๐ฎ๐ซ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐๐ซ๐จ๐ฏ๐ข๐๐๐ฌ ๐๐จ๐ฎ ๐๐ง๐ฌ๐ฐ๐๐ซ ๐ญ๐จ ๐๐๐ฅ๐จ๐ฐ ๐๐๐ง๐ญ๐ข๐จ๐ง๐๐ ๐๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง:
โข Which are the driving factors responsible for the growth of market?
โข Which are the roadblock factors of this market?
โข What are the new opportunities, by which market will grow in coming years?
โข What are the trends of this market?
โข Which are main factors responsible for new product launch?
โข How big is the global & regional market in terms of revenue, sales and production?
โข How far will the market grow in forecast period in terms of revenue, sales and production?
โข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โข Which region has more opportunities?
Region Analysis
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐๐ญ๐๐ข๐ฅ๐ฌ:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
David Correa
Allied Market Research
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.